Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Matrix Biomed, Inc.

Home Clinical Trial Sponsors and OrganizationsMatrix Biomed, Inc.

Matrix Biomed, Inc.

ACTIVE

2301 Dupont Dr Ste 420, 加利福尼亚州奥兰治县, California, United Stateswww.matrixbiomed.comPrivate11–50 employeesEstablished: 2011-01-01

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

6

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2011

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 2

4

66.7%

Trial Status Distribution

Available

2

33.3%

Recruiting

1

16.7%

Unknown

3

50.0%

Clinical Trials

Trials sponsored by this organization (6)

MBM-01 (Tempol) for the Treatment of Ataxia Telangiectasia

Jul 202120 participants

MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)

Jun 202155 participants

MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer

May 202155 participants

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

May 2019120 participants

Treatment of Metastatic Cancer in Terminally Diagnosed Patients

expanded access

A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer

expanded access

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials6
Approvals
News

Back to Organizations